{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:05:43Z","timestamp":1794006343993,"version":"4.8.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR071722"],"award-info":[{"award-number":["R01AR071722"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR071722"],"award-info":[{"award-number":["R01AR071722"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","award":["Anesthesiology Research Funds"],"award-info":[{"award-number":["Anesthesiology Research Funds"]}],"id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with advanced stage cancers frequently suffer from severe pain as a result of bone metastasis and bone destruction, for which there is no efficacious treatment. Here, using multiple mouse models of bone cancer, we report that agonists of the immune regulator STING (stimulator of interferon genes) confer remarkable protection against cancer pain, bone destruction, and local tumor burden. Repeated systemic administration of STING agonists robustly attenuates bone cancer-induced pain and improves locomotor function. Interestingly, STING agonists produce acute pain relief through direct neuronal modulation. Additionally, STING agonists protect against local bone destruction and reduce local tumor burden through modulation of osteoclast and immune cell function in the tumor microenvironment, providing long-term cancer pain relief. Finally, these in vivo effects are dependent on host-intrinsic STING and IFN-I signaling. Overall, STING activation provides unique advantages in controlling bone cancer pain through distinct and synergistic actions on nociceptors, immune cells, and osteoclasts.<\/jats:p>","DOI":"10.1038\/s41467-021-24867-2","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T06:02:50Z","timestamp":1627365770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":137,"title":["STING suppresses bone cancer pain via immune and neuronal modulation"],"prefix":"10.1038","volume":"12","author":[{"given":"Kaiyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2487-8881","authenticated-orcid":false,"given":"Christopher R.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-9036","authenticated-orcid":false,"given":"Yihan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueshu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9092-0075","authenticated-orcid":false,"given":"Sangsu","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9146-2205","authenticated-orcid":false,"given":"Aidan","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3165-267X","authenticated-orcid":false,"given":"Matthew J.","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9355-3688","authenticated-orcid":false,"given":"Ru-Rong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"key":"24867_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher, K. N., Guise, T. A. & McCauley, L. K. Cancer to bone: a fatal attraction. Nat. Rev. Cancer 11, 411\u2013425, https:\/\/doi.org\/10.1038\/nrc3055 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"24867_CR2","doi-asserted-by":"publisher","first-page":"e867","DOI":"10.1097\/pr9.0000000000000867","volume":"6","author":"AS Andriessen","year":"2021","unstructured":"Andriessen, A. S., Donnelly, C. R. & Ji, R.-R. Reciprocal interactions between osteoclasts and nociceptive sensory neurons in bone cancer pain. PAIN Rep. 6, e867, https:\/\/doi.org\/10.1097\/pr9.0000000000000867 (2021).","journal-title":"PAIN Rep."},{"key":"24867_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/annonc\/mdn700","volume":"20","author":"M Costantini","year":"2009","unstructured":"Costantini, M. et al. Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients\u2019 life. Results of an Italian mortality follow-back survey. Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol. 20, 729\u2013735, https:\/\/doi.org\/10.1093\/annonc\/mdn700 (2009).","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"key":"24867_CR4","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/annonc\/mdi191","volume":"16","author":"CS Cleeland","year":"2005","unstructured":"Cleeland, C. S. et al. Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol. 16, 972\u2013980, https:\/\/doi.org\/10.1093\/annonc\/mdi191 (2005).","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"key":"24867_CR5","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/jco.2013.51.7219","volume":"32","author":"S Falk","year":"2014","unstructured":"Falk, S. & Dickenson, A. H. Pain and nociception: mechanisms of cancer-induced bone pain. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 32, 1647\u20131654, https:\/\/doi.org\/10.1200\/jco.2013.51.7219 (2014).","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"24867_CR6","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"MH van den Beuken-van Everdingen","year":"2016","unstructured":"van den Beuken-van Everdingen, M. H., Hochstenbach, L. M., Joosten, E. A., Tjan-Heijnen, V. C. & Janssen, D. J. Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. J. Pain. Symptom Manag. 51, 1070\u20131090.e1079, https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.12.340 (2016).","journal-title":"J. Pain. Symptom Manag."},{"key":"24867_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/SPC.0000000000000496","volume":"14","author":"HM Ellingson","year":"2020","unstructured":"Ellingson, H. M. & Vanderah, T. W. Potential therapeutic treatments of cancer-induced bone pain. Curr. Opin. Support Palliat. Care 14, 107\u2013111, https:\/\/doi.org\/10.1097\/SPC.0000000000000496 (2020).","journal-title":"Curr. Opin. Support Palliat. Care"},{"key":"24867_CR8","doi-asserted-by":"publisher","first-page":"6243s","DOI":"10.1158\/1078-0432.ccr-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman, R. E. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 12, 6243s\u20136249s, https:\/\/doi.org\/10.1158\/1078-0432.ccr-06-0931 (2006).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"24867_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00520-008-0418-0","volume":"16","author":"L Costa","year":"2008","unstructured":"Costa, L., Badia, X., Chow, E., Lipton, A. & Wardley, A. Impact of skeletal complications on patients\u2019 quality of life, mobility, and functional independence. Supportive Care Cancer.: Off. J. Multinatl. Assoc. Supportive Care Cancer. 16, 879\u2013889, https:\/\/doi.org\/10.1007\/s00520-008-0418-0 (2008).","journal-title":"Supportive Care Cancer.: Off. J. Multinatl. Assoc. Supportive Care Cancer."},{"key":"24867_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpain.2016.10.020","volume":"18","author":"JA Paice","year":"2017","unstructured":"Paice, J. A. et al. AAPT diagnostic criteria for chronic cancer pain conditions. J. Pain. 18, 233\u2013246, https:\/\/doi.org\/10.1016\/j.jpain.2016.10.020 (2017).","journal-title":"J. Pain."},{"key":"24867_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/jpet.119.262337","volume":"373","author":"AL Thompson","year":"2020","unstructured":"Thompson, A. L. et al. The endocannabinoid system alleviates pain in a murine model of cancer-induced bone pain. J. Pharm. Exp. Ther. 373, 230\u2013238, https:\/\/doi.org\/10.1124\/jpet.119.262337 (2020).","journal-title":"J. Pharm. Exp. Ther."},{"key":"24867_CR12","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11","author":"L Corrales","year":"2015","unstructured":"Corrales, L. et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 11, 1018\u20131030, https:\/\/doi.org\/10.1016\/j.celrep.2015.04.031 (2015).","journal-title":"Cell Rep."},{"key":"24867_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11998-w","volume":"10","author":"MV Guerin","year":"2019","unstructured":"Guerin, M. V. et al. TGFbeta blocks IFNalpha\/beta release and tumor rejection in spontaneous mammary tumors. Nat. Commun. 10, 4131, https:\/\/doi.org\/10.1038\/s41467-019-11998-w (2019).","journal-title":"Nat. Commun."},{"key":"24867_CR14","doi-asserted-by":"publisher","first-page":"e1346765","DOI":"10.1080\/2162402x.2017.1346765","volume":"6","author":"JM Weiss","year":"2017","unstructured":"Weiss, J. M. et al. The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression. Oncoimmunology 6, e1346765, https:\/\/doi.org\/10.1080\/2162402x.2017.1346765 (2017).","journal-title":"Oncoimmunology"},{"key":"24867_CR15","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1016\/j.celrep.2018.11.047","volume":"25","author":"KE Sivick","year":"2018","unstructured":"Sivick, K. E. et al. Magnitude of therapeutic STING activation determines CD8(+) t cell-mediated anti-tumor immunity. Cell Rep. 25, 3074\u20133085.e3075, https:\/\/doi.org\/10.1016\/j.celrep.2018.11.047 (2018).","journal-title":"Cell Rep."},{"key":"24867_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.Cd-19-0761","volume":"10","author":"J Kwon","year":"2020","unstructured":"Kwon, J. & Bakhoum, S. F. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer. Cancer Discov. 10, 26\u201339, https:\/\/doi.org\/10.1158\/2159-8290.Cd-19-0761 (2020).","journal-title":"Cancer Discov."},{"key":"24867_CR17","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1158\/2326-6066.Cir-14-0099","volume":"2","author":"T Ohkuri","year":"2014","unstructured":"Ohkuri, T. et al. STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment. Cancer Immunol. Res 2, 1199\u20131208, https:\/\/doi.org\/10.1158\/2326-6066.Cir-14-0099 (2014).","journal-title":"Cancer Immunol. Res"},{"key":"24867_CR18","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1158\/1078-0432.Ccr-17-2807","volume":"24","author":"YS Tan","year":"2018","unstructured":"Tan, Y. S. et al. Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine. Clin. Cancer Res 24, 4242\u20134255, https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-2807 (2018).","journal-title":"Clin. Cancer Res"},{"key":"24867_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nnano.2017.52","volume":"12","author":"M Luo","year":"2017","unstructured":"Luo, M. et al. A STING-activating nanovaccine for cancer immunotherapy. Nat. Nanotechnol. 12, 648\u2013654, https:\/\/doi.org\/10.1038\/nnano.2017.52 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"24867_CR20","doi-asserted-by":"publisher","unstructured":"Cheng, N. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.120638 (2018).","DOI":"10.1172\/jci.insight.120638"},{"key":"24867_CR21","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1200\/JCO.2019.37.15_suppl.2507","volume":"37","author":"F Meric-Bernstam","year":"2019","unstructured":"Meric-Bernstam, F. et al. Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced\/metastatic solid tumors or lymphomas. J. Clin. Oncol. 37, 2507\u20132507, https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.2507 (2019).","journal-title":"J. Clin. Oncol."},{"key":"24867_CR22","doi-asserted-by":"publisher","first-page":"viii712","DOI":"10.1093\/annonc\/mdy424.015","volume":"29","author":"KJ Harrington","year":"2018","unstructured":"Harrington, K. J. et al. Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas. Ann. Oncol. 29, viii712, https:\/\/doi.org\/10.1093\/annonc\/mdy424.015 (2018).","journal-title":"Ann. Oncol."},{"key":"24867_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-020-03151-1","volume":"591","author":"CR Donnelly","year":"2021","unstructured":"Donnelly, C. R. et al. STING controls nociception via type I interferon signalling in sensory neurons. Nature 591, 275\u2013280, https:\/\/doi.org\/10.1038\/s41586-020-03151-1 (2021).","journal-title":"Nature"},{"key":"24867_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.critrevonc.2017.05.004","volume":"117","author":"ZZ Reinstein","year":"2017","unstructured":"Reinstein, Z. Z. et al. Overcoming immunosuppression in bone metastases. Crit. Rev. Oncol. Hematol. 117, 114\u2013127, https:\/\/doi.org\/10.1016\/j.critrevonc.2017.05.004 (2017).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"24867_CR25","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.4049\/jimmunol.1501496","volume":"196","author":"HY Yim","year":"2016","unstructured":"Yim, H. Y. et al. Elevated response to type I IFN enhances RANKL-mediated osteoclastogenesis in Usp18-knockout mice. J. Immunol. (Baltim., Md.: 1950) 196, 3887\u20133895, https:\/\/doi.org\/10.4049\/jimmunol.1501496 (2016).","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"key":"24867_CR26","doi-asserted-by":"publisher","first-page":"11917","DOI":"10.1073\/pnas.0502188102","volume":"102","author":"LF Coelho,","year":"2005","unstructured":"Coelho,, L. F., Magno de Freitas Almeida, G., Mennechet, F. J., Blangy, A. & Uze, G. Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression. Proc. Natl Acad. Sci. USA 102, 11917\u201311922, https:\/\/doi.org\/10.1073\/pnas.0502188102 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"24867_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/art.39863","volume":"69","author":"R Baum","year":"2017","unstructured":"Baum, R. et al. STING contributes to abnormal bone formation induced by deficiency of DNase II in mice. Arth Rheumatol. (Hoboken, N. J.) 69, 460\u2013471, https:\/\/doi.org\/10.1002\/art.39863 (2017).","journal-title":"Arth Rheumatol. (Hoboken, N. J.)"},{"key":"24867_CR28","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/jbmr.3701","volume":"34","author":"Y Kwon","year":"2019","unstructured":"Kwon, Y. et al. Cyclic dinucleotides inhibit osteoclast differentiation through STING-mediated interferon-beta signaling. J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res. 34, 1366\u20131375, https:\/\/doi.org\/10.1002\/jbmr.3701 (2019).","journal-title":"J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res."},{"key":"24867_CR29","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1200\/jco.2001.19.15.3562","volume":"19","author":"GD Roodman","year":"2001","unstructured":"Roodman, G. D. Biology of osteoclast activation in cancer. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 19, 3562\u20133571, https:\/\/doi.org\/10.1200\/jco.2001.19.15.3562 (2001).","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"24867_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133334","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. PD-1 blockade inhibits osteoclast formation and murine bone cancer pain. J. Clin. Invest https:\/\/doi.org\/10.1172\/JCI133334 (2020).","journal-title":"J. Clin. Invest"},{"key":"24867_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/ijwh.s24783","volume":"4","author":"G Hampson","year":"2012","unstructured":"Hampson, G. & Fogelman, I. Clinical role of bisphosphonate therapy. Int. J. women\u2019s health 4, 455\u2013469, https:\/\/doi.org\/10.2147\/ijwh.s24783 (2012).","journal-title":"Int. J. women\u2019s health"},{"key":"24867_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13058-017-0815-8","volume":"19","author":"JM Ubellacker","year":"2017","unstructured":"Ubellacker, J. M. et al. Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells. Breast cancer Res.: BCR 19, 23, https:\/\/doi.org\/10.1186\/s13058-017-0815-8 (2017).","journal-title":"Breast cancer Res.: BCR"},{"key":"24867_CR33","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.pain.2013.07.044","volume":"154","author":"P Mantyh","year":"2013","unstructured":"Mantyh, P. Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain 154, S54\u2013S62 (2013).","journal-title":"Pain"},{"key":"24867_CR34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/1073858414525828","volume":"20","author":"BL Schmidt","year":"2014","unstructured":"Schmidt, B. L. The neurobiology of cancer pain. Neuroscientist 20, 546\u2013562 (2014).","journal-title":"Neuroscientist"},{"key":"24867_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc747","volume":"2","author":"PW Mantyh","year":"2002","unstructured":"Mantyh, P. W., Clohisy, D. R., Koltzenburg, M. & Hunt, S. P. Molecular mechanisms of cancer pain. Nat. Rev. Cancer 2, 201\u2013209 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"24867_CR36","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/74999","volume":"6","author":"P Honore","year":"2000","unstructured":"Honore, P. et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat. Med 6, 521\u2013528, https:\/\/doi.org\/10.1038\/74999 (2000).","journal-title":"Nat. Med"},{"key":"24867_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejca.2016.10.021","volume":"71","author":"R von Moos","year":"2017","unstructured":"von Moos, R., Costa, L., Ripamonti, C. I., Niepel, D. & Santini, D. Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain. Eur. J. cancer (Oxf., Engl.: 1990) 71, 80\u201394, https:\/\/doi.org\/10.1016\/j.ejca.2016.10.021 (2017).","journal-title":"Eur. J. cancer (Oxf., Engl.: 1990)"},{"key":"24867_CR38","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1200\/jco.2011.36.8902","volume":"29","author":"H Miao","year":"2011","unstructured":"Miao, H. et al. Incidence and outcome of male breast cancer: an international population-based study. J. Clin. Oncol. 29, 4381\u20134386, https:\/\/doi.org\/10.1200\/jco.2011.36.8902 (2011).","journal-title":"J. Clin. Oncol."},{"key":"24867_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00774-018-0927-y","volume":"37","author":"T Hiraga","year":"2019","unstructured":"Hiraga, T. & Ninomiya, T. Establishment and characterization of a C57BL\/6 mouse model of bone metastasis of breast cancer. J. bone Miner. Metab. 37, 235\u2013242, https:\/\/doi.org\/10.1007\/s00774-018-0927-y (2019).","journal-title":"J. bone Miner. Metab."},{"key":"24867_CR40","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1128\/iai.00999-10","volume":"79","author":"JD Sauer","year":"2011","unstructured":"Sauer, J. D. et al. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79, 688\u2013694, https:\/\/doi.org\/10.1128\/iai.00999-10 (2011).","journal-title":"Infect. Immun."},{"key":"24867_CR41","doi-asserted-by":"publisher","unstructured":"Khoo, L. T. & Chen, L. Y. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches. EMBO reports 19, https:\/\/doi.org\/10.15252\/embr.201846935 (2018).","DOI":"10.15252\/embr.201846935"},{"key":"24867_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12031-011-9552-0","volume":"46","author":"R Cannarsa","year":"2012","unstructured":"Cannarsa, R., Carretta, D., Lattanzio, F., Candeletti, S. & Romualdi, P. \u2206(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells. J. Mol. Neurosci. 46, 285\u2013292 (2012).","journal-title":"J. Mol. Neurosci."},{"key":"24867_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/ALN.0b013e31823de68d","volume":"116","author":"BX Ren","year":"2012","unstructured":"Ren, B. X. et al. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist\/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model. Anesthesiology 116, 122\u2013132, https:\/\/doi.org\/10.1097\/ALN.0b013e31823de68d (2012).","journal-title":"Anesthesiology"},{"key":"24867_CR44","doi-asserted-by":"publisher","first-page":"891","DOI":"10.4049\/jimmunol.1501648","volume":"196","author":"JM Poczobutt","year":"2016","unstructured":"Poczobutt, J. M. et al. Deletion of 5-lipoxygenase in the tumor microenvironment promotes lung cancer progression and metastasis through regulating T cell recruitment. J. Immunol. (Baltim., Md.: 1950) 196, 891\u2013901, https:\/\/doi.org\/10.4049\/jimmunol.1501648 (2016).","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"key":"24867_CR45","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.molmed.2019.02.007","volume":"25","author":"G Berger","year":"2019","unstructured":"Berger, G., Marloye, M. & Lawler, S. E. Pharmacological Modulation of the STING Pathway for Cancer Immunotherapy. Trends Mol. Med. 25, 412\u2013427, https:\/\/doi.org\/10.1016\/j.molmed.2019.02.007 (2019).","journal-title":"Trends Mol. Med."},{"key":"24867_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05366-3","volume":"9","author":"T Kuchimaru","year":"2018","unstructured":"Kuchimaru, T. et al. A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries. Nat. Commun. 9, 2981, https:\/\/doi.org\/10.1038\/s41467-018-05366-3 (2018).","journal-title":"Nat. Commun."},{"key":"24867_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tranon.2016.12.001","volume":"10","author":"M Martin-Fernandez","year":"2017","unstructured":"Martin-Fernandez, M. et al. The usefulness of bone biomarkers for monitoring treatment disease: a comparative study in osteolytic and osteosclerotic bone metastasis models. Transl. Oncol. 10, 255\u2013261, https:\/\/doi.org\/10.1016\/j.tranon.2016.12.001 (2017).","journal-title":"Transl. Oncol."},{"key":"24867_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.lungcan.2015.04.007","volume":"89","author":"M Kuchuk","year":"2015","unstructured":"Kuchuk, M. et al. The incidence and clinical impact of bone metastases in non-small cell lung cancer. Lung cancer (Amst., Neth.) 89, 197\u2013202, https:\/\/doi.org\/10.1016\/j.lungcan.2015.04.007 (2015).","journal-title":"Lung cancer (Amst., Neth.)"},{"key":"24867_CR49","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4081\/oncol.2017.321","volume":"11","author":"F Macedo","year":"2017","unstructured":"Macedo, F. et al. Bone metastases: an overview. Oncol. Rev. 11, 321, https:\/\/doi.org\/10.4081\/oncol.2017.321 (2017).","journal-title":"Oncol. Rev."},{"key":"24867_CR50","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.immuni.2013.02.024","volume":"38","author":"T Kawashima","year":"2013","unstructured":"Kawashima, T. et al. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-beta. Immunity 38, 1187\u20131197, https:\/\/doi.org\/10.1016\/j.immuni.2013.02.024 (2013).","journal-title":"Immunity"},{"key":"24867_CR51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv, L. B. & Donlin, L. T. Regulation of type I interferon responses. Nat. Rev. Immunol. 14, 36\u201349, https:\/\/doi.org\/10.1038\/nri3581 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"24867_CR52","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/jbmr.1588","volume":"27","author":"K Sj\u00f6gren","year":"2012","unstructured":"Sj\u00f6gren, K. et al. The gut microbiota regulates bone mass in mice. J. Bone Min. Res 27, 1357\u20131367, https:\/\/doi.org\/10.1002\/jbmr.1588 (2012).","journal-title":"J. Bone Min. Res"},{"key":"24867_CR53","doi-asserted-by":"publisher","first-page":"E7554","DOI":"10.1073\/pnas.1607235113","volume":"113","author":"J Yan","year":"2016","unstructured":"Yan, J. et al. Gut microbiota induce IGF-1 and promote bone formation and growth. Proc. Natl Acad. Sci. USA 113, E7554\u2013E7563, https:\/\/doi.org\/10.1073\/pnas.1607235113 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"24867_CR54","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1523\/JNEUROSCI.5250-14.2015","volume":"35","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. Delayed activation of spinal microglia contributes to the maintenance of bone cancer pain in female wistar rats via P2X7 receptor and IL-18. J. Neurosci. 35, 7950\u20137963 (2015).","journal-title":"J. Neurosci."},{"key":"24867_CR55","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","volume":"100","author":"G Chen","year":"2018","unstructured":"Chen, G., Zhang, Y. Q., Qadri, Y. J., Serhan, C. N. & Ji, R. R. Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain. Neuron 100, 1292\u20131311, https:\/\/doi.org\/10.1016\/j.neuron.2018.11.009 (2018).","journal-title":"Neuron"},{"key":"24867_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.expneurol.2004.11.028","volume":"193","author":"CM Peters","year":"2005","unstructured":"Peters, C. M. et al. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp. Neurol. 193, 85\u2013100, https:\/\/doi.org\/10.1016\/j.expneurol.2004.11.028 (2005).","journal-title":"Exp. Neurol."},{"key":"24867_CR57","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1523\/jneurosci.3055-19.2020","volume":"40","author":"P Barrag\u00e1n-Iglesias","year":"2020","unstructured":"Barrag\u00e1n-Iglesias, P. et al. Type I interferons act directly on nociceptors to produce pain sensitization: implications for viral infection-induced pain. J. Neurosci. 40, 3517\u20133532, https:\/\/doi.org\/10.1523\/jneurosci.3055-19.2020 (2020).","journal-title":"J. Neurosci."},{"key":"24867_CR58","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/nm.3978","volume":"21","author":"ZZ Xu","year":"2015","unstructured":"Xu, Z. Z. et al. Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade. Nat. Med 21, 1326\u20131331, https:\/\/doi.org\/10.1038\/nm.3978 (2015).","journal-title":"Nat. Med"},{"key":"24867_CR59","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1172\/jci80883","volume":"125","author":"G Chen","year":"2015","unstructured":"Chen, G., Park, C. K., Xie, R. G. & Ji, R. R. Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-beta secretion. J. Clin. Investig. 125, 3226\u20133240, https:\/\/doi.org\/10.1172\/jci80883 (2015).","journal-title":"J. Clin. Investig."},{"key":"24867_CR60","doi-asserted-by":"publisher","unstructured":"Wang, Z. et al. Anti-PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaw6471 (2020).","DOI":"10.1126\/scitranslmed.aaw6471"},{"key":"24867_CR61","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fphar.2018.00412","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Distinct analgesic actions of DHA and DHA-derived specialized pro-resolving mediators on post-operative pain after bone fracture in mice. Front Pharm. 9, 412, https:\/\/doi.org\/10.3389\/fphar.2018.00412 (2018).","journal-title":"Front Pharm."},{"key":"24867_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M. & Yaksh, T. L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53, 55\u201363 (1994).","journal-title":"J. Neurosci. Methods"},{"key":"24867_CR63","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1172\/jci80672","volume":"126","author":"C Wang","year":"2016","unstructured":"Wang, C. et al. NOTCH signaling in skeletal progenitors is critical for fracture repair. J. Clin. Investig. 126, 1471\u20131481, https:\/\/doi.org\/10.1172\/jci80672 (2016).","journal-title":"J. Clin. Investig."},{"key":"24867_CR64","doi-asserted-by":"publisher","unstructured":"Cao, C. et al. Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency-induced bone loss. JCI insight. https:\/\/doi.org\/10.1172\/jci.insight.95512 (2017).","DOI":"10.1172\/jci.insight.95512"},{"key":"24867_CR65","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/jbmr.1732","volume":"28","author":"AN Lozano-Ondoua","year":"2013","unstructured":"Lozano-Ondoua, A. N. et al. Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists. J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res. 28, 92\u2013107, https:\/\/doi.org\/10.1002\/jbmr.1732 (2013).","journal-title":"J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24867-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24867-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24867-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:43:37Z","timestamp":1669970617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24867-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["24867"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-24867-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.18.426944","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]},"assertion":[{"value":"21 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.R.J. is a consultant of Boston Scientific and received a research grant from the company. This activity is not related to this study. R.R.J. and C.R.D. filed a patent on STING-related treatment for cancer pain: \u201cCOMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN\u201d (PCT\/US2021\/028384). All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4558"}}